Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",41642,226,1.11 [0.87-1.41],0.4066325074338374
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",43076,323,1.10 [0.91-1.35],0.3265600784241214
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",42641,2260,1.04 [0.96-1.13],0.3210828982919556
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Candidiasis,43107,697,1.08 [0.94-1.24],0.3011289666283967
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,41796,5745,1.01 [0.96-1.07],0.6168770238439603
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),42001,5230,1.01 [0.96-1.07],0.6270116712945226
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,42697,1995,1.03 [0.95-1.12],0.5000255083168865
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,42960,142,1.20 [0.92-1.58],0.1848790210148884
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,39755,1551,1.01 [0.91-1.11],0.903287453914852
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,38386,1738,1.03 [0.94-1.14],0.4844902840091271
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,38247,406,1.05 [0.87-1.27],0.6250561526029488
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,30235,3204,1.00 [0.93-1.07],0.9648822877614766
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,38007,641,1.16 [1.02-1.33],0.0279261881606875
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,43048,2346,1.06 [0.99-1.15],0.1071396283897413
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Mycoses,43230,820,1.05 [0.92-1.19],0.4810948219934365
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,41890,1509,1.06 [0.96-1.17],0.2299250510031732
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,43123,1707,1.02 [0.93-1.12],0.6780330691362232
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,41027,325,1.11 [0.91-1.35],0.3218371124803405
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,43321,77,1.01 [0.65-1.58],0.957476717712709
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other septicaemia,42913,1497,1.02 [0.92-1.13],0.7177495602607974
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,42943,125,1.04 [0.74-1.46],0.8260281819299193
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other viral diseases,43180,260,1.13 [0.92-1.40],0.2446819306703577
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",43152,232,1.07 [0.85-1.36],0.5670355995363561
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,41053,672,1.03 [0.89-1.20],0.6713455394074515
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,40838,457,1.03 [0.86-1.24],0.7136610768088467
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,40871,169,1.30 [1.04-1.64],0.0238078139799253
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,43280,88,0.59 [0.33-1.05],0.0749824963419859
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,43206,263,1.07 [0.86-1.35],0.5317419786851549
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral warts,43028,85,0.99 [0.65-1.52],0.9714430987570322
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],43058,115,1.28 [0.97-1.70],0.0801755587623119
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm,42819,489,0.96 [0.80-1.15],0.6245332949123873
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,43171,98,1.11 [0.79-1.58],0.5392765542828952
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,43132,107,0.98 [0.67-1.44],0.9335171373607184
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,19825,107,0.84 [0.55-1.29],0.4318892979129157
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",42757,2391,1.00 [0.92-1.08],0.961245942808889
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm of meninges,43296,99,0.84 [0.54-1.32],0.4562028640037081
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,43213,114,1.03 [0.73-1.47],0.8494271607926259
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,43278,179,1.08 [0.82-1.42],0.5777192581920156
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm of ovary,23387,148,1.12 [0.85-1.48],0.4316327613740247
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Ascending colon,43279,610,1.10 [0.96-1.28],0.1806641206336942
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Caecum,43288,499,0.98 [0.82-1.17],0.8076602688289389
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",43132,118,1.09 [0.78-1.52],0.6019340717470596
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Descending colon,43282,371,0.84 [0.66-1.06],0.1474439826886972
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Rectum,43206,584,0.93 [0.78-1.11],0.4243938738965219
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,43118,1044,1.03 [0.92-1.16],0.5943502748940904
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Transverse colon,43272,704,1.03 [0.89-1.19],0.6976473395857129
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Carcinoma in situ of breast,19003,118,1.05 [0.75-1.47],0.7719675592919352
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19073,136,0.88 [0.61-1.27],0.4890596741295936
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",34555,92,0.88 [0.56-1.38],0.5907213659470597
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",34577,114,0.73 [0.47-1.16],0.1828123242831985
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",43233,202,1.28 [1.04-1.57],0.0217462430575791
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Haemangioma, any site",43234,197,1.28 [1.04-1.58],0.0225738386076015
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Leiomyoma of uterus,22605,487,1.08 [0.93-1.27],0.3150739850447755
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Lung cancer and mesothelioma,30092,568,0.94 [0.81-1.11],0.4793994061666995
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Lymphoid leukaemia,34552,89,1.03 [0.69-1.54],0.8849601048364472
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",34776,313,1.02 [0.82-1.26],0.8549066890963484
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",34795,332,0.86 [0.67-1.09],0.2160691487755852
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19204,165,1.24 [0.97-1.59],0.0837967586742397
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",34599,136,1.02 [0.73-1.42],0.9075541751379193
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",34630,167,1.14 [0.88-1.49],0.3157236289322929
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",34633,170,0.99 [0.73-1.34],0.9347036175779057
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19161,122,0.90 [0.62-1.32],0.6005391406951056
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",34622,159,0.68 [0.46-1.02],0.0628168104940046
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",16567,1143,0.81 [0.70-0.93],0.002258707332196
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",34661,198,1.07 [0.82-1.39],0.6146161726000648
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",34586,123,0.67 [0.42-1.07],0.0949372235959707
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,34635,172,0.95 [0.70-1.30],0.7478852031930852
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Melanocytic naevi,42996,349,0.99 [0.81-1.22],0.924820475642977
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Melanocytic naevi of trunk,43259,154,0.72 [0.48-1.06],0.0936631318008767
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Melanoma in situ,34518,137,0.65 [0.42-1.01],0.0541630970635497
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",34617,154,0.76 [0.52-1.11],0.1560389085693094
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",34731,268,0.92 [0.71-1.19],0.5250863644202155
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",34856,393,0.87 [0.70-1.08],0.2190405233783995
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",34629,166,0.81 [0.57-1.16],0.2549316149605197
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Other benign neoplasms of skin,43017,272,1.16 [0.94-1.41],0.1592140161265859
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",36238,1775,0.95 [0.86-1.04],0.2727302537281514
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",36334,1871,0.97 [0.88-1.06],0.498485860828876
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,42820,573,1.06 [0.91-1.24],0.4584514889454976
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,40220,146,1.08 [0.80-1.47],0.5989725679749642
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,42372,125,0.98 [0.68-1.39],0.8957159411341058
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,42023,4768,1.08 [1.03-1.14],0.0036713655896055
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,40940,78,1.01 [0.64-1.58],0.9822738999372758
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,42632,85,0.94 [0.60-1.47],0.7801754050839926
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,42546,2472,1.08 [1.00-1.16],0.0456964778206018
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,42544,2470,1.08 [1.00-1.16],0.0444424203851701
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,40217,143,1.08 [0.79-1.47],0.6322606571905833
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,42786,1924,1.04 [0.96-1.14],0.337459886736444
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,42737,190,1.22 [0.97-1.53],0.0870328368203207
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,42350,103,1.32 [0.99-1.75],0.0560330785366274
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,42354,107,1.11 [0.79-1.57],0.5498521223815334
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,42998,451,1.12 [0.95-1.32],0.180947896818245
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,43145,91,1.21 [0.88-1.68],0.2437157809282042
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",42922,375,1.10 [0.92-1.32],0.306289769728774
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,41033,171,1.13 [0.87-1.48],0.3537035894937468
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,33618,504,1.24 [1.08-1.43],0.0028601680062033
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,40395,191,0.86 [0.62-1.18],0.3400885934813343
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,40415,211,0.95 [0.70-1.28],0.7146813532532301
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,33205,91,1.18 [0.83-1.68],0.3540166681546254
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,40273,106,0.65 [0.39-1.07],0.091896029572068
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,39354,387,1.11 [0.93-1.33],0.2617344879233163
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",42568,876,0.89 [0.77-1.03],0.1202874381755599
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,42136,444,0.88 [0.72-1.08],0.2254855624694003
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,41864,172,1.07 [0.80-1.42],0.6486720859239707
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,42747,2580,0.95 [0.88-1.03],0.1977836117169562
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,37829,2511,0.95 [0.88-1.03],0.210961466868712
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",33222,108,0.91 [0.60-1.38],0.658403861204217
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",40025,137,0.87 [0.60-1.26],0.4709599835123733
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,33575,461,1.06 [0.89-1.27],0.4950427859651329
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,33216,102,1.30 [0.97-1.74],0.0789849569264013
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,38997,5883,1.00 [0.95-1.05],0.9542328824079324
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,33447,333,0.84 [0.65-1.07],0.159738432714368
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,34041,927,1.04 [0.91-1.18],0.5689902638508639
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,43193,524,1.08 [0.93-1.27],0.3104708061849101
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,42878,209,1.09 [0.85-1.39],0.5047614519110348
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,33327,213,0.99 [0.76-1.30],0.9644785835417118
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",33216,102,0.97 [0.65-1.45],0.8991011960441461
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,42423,2535,1.02 [0.95-1.10],0.6094318682369647
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,33521,407,1.11 [0.93-1.32],0.2392681749441463
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,33560,446,1.05 [0.87-1.26],0.6142460440828394
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",34167,1053,1.02 [0.91-1.15],0.7360419541643919
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,33295,181,1.15 [0.89-1.49],0.2966607516929754
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,42867,198,1.11 [0.87-1.43],0.407668418538251
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,34115,1001,1.12 [1.01-1.26],0.0402403685917059
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,33912,798,1.00 [0.87-1.15],0.9650778492961796
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,39074,107,1.32 [1.00-1.75],0.0487324654946872
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,41424,8310,1.02 [0.97-1.06],0.4872502096548495
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,39961,73,0.93 [0.57-1.51],0.7727023022178824
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,39985,97,1.21 [0.88-1.67],0.2318190070208678
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,43022,3209,0.98 [0.91-1.05],0.5372395437374471
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",43022,3203,0.98 [0.92-1.05],0.589786225773803
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,39970,82,0.89 [0.56-1.43],0.6323517981941534
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,42743,2022,0.99 [0.91-1.08],0.8655117264178231
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",35700,2586,1.07 [0.99-1.15],0.0870004655663604
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,43304,347,1.01 [0.82-1.25],0.9184067097557604
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,41815,123,0.85 [0.57-1.28],0.4365121304791335
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,40898,177,0.95 [0.70-1.28],0.7210753672322714
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,40963,242,0.84 [0.63-1.12],0.2231726773480394
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",33382,268,0.97 [0.76-1.24],0.8073412552937126
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,39436,255,1.08 [0.85-1.36],0.5209228914393357
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,3553,138,0.95 [0.66-1.36],0.7738064938880622
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,3783,414,0.97 [0.79-1.19],0.7813623368738009
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,39283,102,0.97 [0.64-1.49],0.8958311785849086
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,3492,78,1.13 [0.76-1.68],0.5387682261237103
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,42287,3106,1.01 [0.94-1.08],0.8366174796820368
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,42243,551,0.94 [0.78-1.12],0.4644961054408943
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,39574,607,1.16 [1.01-1.33],0.0308968614344928
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,34339,1225,1.15 [1.04-1.27],0.0063103720984096
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",43126,407,1.02 [0.85-1.24],0.8032050887544883
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),41441,276,1.16 [0.94-1.45],0.1733449501597959
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Angina pectoris,39633,1952,1.00 [0.91-1.09],0.933305960717151
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Aortic aneurysm,41572,407,1.11 [0.92-1.33],0.2770813361692032
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,41260,95,1.13 [0.77-1.66],0.5190955208505261
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",41491,326,1.29 [1.09-1.53],0.0036265608179249
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,26873,3107,1.00 [0.93-1.07],0.9327451677761118
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,AV-block,36646,703,0.99 [0.85-1.15],0.8832075171407665
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",43220,689,0.86 [0.73-1.02],0.089800159686597
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Cardiac arrest,24077,311,1.04 [0.84-1.30],0.703093523446839
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Cardiomyopathy,36228,285,0.78 [0.59-1.04],0.0890045172678302
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",36104,161,0.83 [0.58-1.19],0.3215351307382735
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,43319,74,0.89 [0.54-1.48],0.6500470908427455
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Conduction disorders,37673,1730,1.05 [0.96-1.15],0.261751553659788
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,41082,3429,1.05 [0.98-1.12],0.1385904241406693
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,37920,12700,0.97 [0.94-1.01],0.1198907387189061
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,DVT of lower extremities,41027,439,1.04 [0.87-1.25],0.6661394048970894
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Endocarditis,36058,115,0.89 [0.60-1.34],0.5821662148778234
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Heart failure, strict",42976,1787,1.00 [0.91-1.10],0.9796597448583452
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypertension,39439,10868,0.98 [0.95-1.02],0.381526817422512
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Hypertension, essential",39453,10882,0.98 [0.95-1.02],0.3571984430581179
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Hypertension, portal",43034,131,1.20 [0.90-1.59],0.2153345103488945
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",28883,312,0.96 [0.76-1.22],0.7602616872989004
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,28728,157,0.99 [0.72-1.37],0.9574666420741732
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypotension,43087,1878,0.94 [0.86-1.04],0.2156249558231023
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,41818,176,0.71 [0.49-1.03],0.0735379287331556
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",41366,3685,1.03 [0.97-1.10],0.2871657869281687
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",42720,921,0.97 [0.85-1.11],0.6733013126784816
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Left bundle-branch block,36547,604,1.07 [0.92-1.25],0.3717561890912738
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,42549,1402,1.05 [0.95-1.16],0.3331899840699496
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",38862,1181,1.09 [0.98-1.21],0.1206236996849741
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",43161,263,0.97 [0.75-1.24],0.7988956691270748
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",43270,525,1.15 [0.99-1.34],0.0698619093736103
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Oesophageal varices,40677,89,1.04 [0.69-1.57],0.8585746122201308
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other aneurysm,41286,121,1.02 [0.71-1.45],0.9327454359999228
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other arrhythmias,36651,708,0.97 [0.83-1.13],0.7075885407952476
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,41333,168,1.20 [0.92-1.57],0.180907919171154
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,41563,398,1.32 [1.14-1.54],0.0003033032494734
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,36239,296,1.12 [0.91-1.37],0.3045669155717305
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other disorders of veins,40735,147,1.20 [0.92-1.57],0.1718253875968253
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,40670,82,1.02 [0.67-1.56],0.9167883980796732
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,40973,107,1.11 [0.79-1.56],0.5571773861562859
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,40804,216,0.99 [0.76-1.30],0.9590120297600344
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,37626,1683,1.08 [0.99-1.18],0.1022585285687173
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,41299,90,0.85 [0.53-1.36],0.5087858476474354
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,42061,896,1.10 [0.98-1.25],0.1096123739942392
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,42286,585,1.02 [0.87-1.20],0.7730461124379998
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",41859,993,0.99 [0.88-1.13],0.9228153159957668
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,24319,553,1.00 [0.84-1.18],0.9573954940307507
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Peripheral artery disease,41773,658,1.11 [0.96-1.28],0.1697866464086573
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),41157,569,1.01 [0.86-1.19],0.882589069582618
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Pulmonary embolism,42484,783,0.99 [0.86-1.14],0.868950725681915
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,43199,1067,1.05 [0.94-1.18],0.3654303695905123
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Right bundle-branch block,36517,574,1.01 [0.85-1.19],0.927069185413726
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Secondary right heart disease,42279,578,1.03 [0.88-1.21],0.6929563331682553
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,41175,309,0.98 [0.78-1.23],0.8762549998762311
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",42698,1056,0.94 [0.82-1.07],0.3228676376506639
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",42665,1121,0.92 [0.81-1.05],0.2016253177559621
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,41776,100,0.67 [0.40-1.11],0.1219340219238687
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,41296,132,0.89 [0.61-1.30],0.5368420822248707
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Transient ischemic attack,42170,371,1.21 [1.03-1.43],0.0238971548676392
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,41578,431,0.92 [0.75-1.13],0.4499040966892459
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Varicose veins,41274,686,1.03 [0.89-1.19],0.7166560264628149
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,41191,143,0.98 [0.70-1.38],0.903767269907491
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Venous thromboembolism,42928,1232,0.99 [0.88-1.10],0.8118623694454791
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",43112,597,1.09 [0.94-1.26],0.2758051149474002
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",37982,2390,0.98 [0.90-1.06],0.582464852657147
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Any mental disorder,42235,6643,0.99 [0.94-1.04],0.6462938180462523
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",43033,698,1.02 [0.88-1.19],0.7462461488269598
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",38223,2631,0.93 [0.86-1.01],0.0743151222766023
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",35733,141,1.11 [0.83-1.49],0.4710151616168465
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Smoking dependency,42422,2302,0.98 [0.90-1.06],0.6309066222585079
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",38317,2725,0.98 [0.91-1.06],0.6380905728359616
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Vascular dementia,42529,209,1.07 [0.83-1.38],0.6210793692441288
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Alzheimer disease,43319,555,0.91 [0.76-1.09],0.2823549769269722
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",29374,97,0.90 [0.58-1.40],0.6358777800284632
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Bell's palsy,40356,139,0.97 [0.70-1.36],0.8666620593031873
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,41045,828,0.94 [0.82-1.08],0.3805097626006001
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Cerebral cysts,42645,382,1.01 [0.83-1.23],0.9397958644864772
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,43183,504,0.96 [0.80-1.16],0.6901729170411144
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,42509,91,1.28 [0.94-1.75],0.1195945324418776
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,43293,109,0.99 [0.68-1.44],0.9563108377701118
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",42384,121,1.02 [0.72-1.45],0.8899209852972867
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Epilepsy,40751,464,0.92 [0.75-1.11],0.3763018065369247
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,42523,2236,0.96 [0.88-1.04],0.3407259033714155
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,43244,692,1.13 [0.99-1.29],0.0804401725238995
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Falls/tendency to fall,42329,4209,0.97 [0.91-1.03],0.3078227909533685
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Generalized epilepsy,42698,88,1.17 [0.82-1.66],0.3832398606574771
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Hemiplegia,43075,396,0.90 [0.73-1.12],0.3555578585859013
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Hydrocephalus,42367,104,0.82 [0.52-1.28],0.3731345310345627
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,43286,116,0.93 [0.63-1.36],0.6984516664315972
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,40343,126,0.92 [0.64-1.32],0.6577395965353909
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,40351,134,0.98 [0.69-1.38],0.8865955105814367
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Memory loss,42288,194,1.04 [0.80-1.37],0.7571231678046939
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Migraine,40881,594,0.98 [0.84-1.15],0.8087891753668506
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",43203,539,1.00 [0.85-1.18],0.957826014423552
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Motor neuron disease,29562,249,1.04 [0.83-1.32],0.7150548019485398
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,43029,178,0.97 [0.72-1.30],0.8328558370420759
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",42208,1991,0.88 [0.80-0.97],0.012031122276377
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Neurological diseases,40832,6070,0.96 [0.91-1.01],0.1166717255006881
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,42721,303,0.90 [0.70-1.15],0.3915372620128825
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",40882,665,0.84 [0.71-1.00],0.0524568661343494
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",43198,483,1.13 [0.97-1.33],0.119798468720168
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,34668,1062,0.94 [0.83-1.06],0.3090913168871956
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,42383,120,0.95 [0.66-1.39],0.8013939953585945
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other disorders of nervous system,42494,231,1.06 [0.83-1.35],0.6589730495609469
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,42800,248,1.17 [0.95-1.45],0.1410282004365578
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other facial nerve disorders,40381,164,0.88 [0.63-1.24],0.4726095254559547
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other headache syndromes,40389,102,0.99 [0.67-1.46],0.9499704323294026
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other neurological diseases,43120,857,1.04 [0.92-1.18],0.541383904277088
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other sleep disorders,41201,914,0.86 [0.74-0.99],0.0380934477497311
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Parkinson's disease,43276,405,1.09 [0.91-1.30],0.3668774985410847
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,42356,93,1.07 [0.74-1.56],0.7106880513331455
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Restless leg syndrome,43317,110,1.08 [0.77-1.53],0.643062520912646
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Sleep apnoea,42928,796,0.89 [0.77-1.03],0.1302780189851411
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Small fibre neuropathy,42795,80,1.10 [0.74-1.64],0.6408176353730499
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,43292,293,1.03 [0.83-1.29],0.7907199189163308
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,40302,85,0.76 [0.45-1.27],0.2922722005208903
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,43319,561,0.90 [0.75-1.08],0.2638191126078482
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),42463,202,1.08 [0.84-1.39],0.5599670979050273
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,42364,160,0.75 [0.51-1.09],0.130979383101634
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,42642,663,1.11 [0.97-1.28],0.1332036683320486
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,43045,387,1.01 [0.83-1.24],0.8990009879044439
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,41634,85,1.28 [0.92-1.78],0.1359752037356464
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,41648,99,0.96 [0.64-1.43],0.8350900045771152
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",43134,90,1.02 [0.68-1.53],0.9144552645484892
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,42890,250,1.04 [0.82-1.32],0.7571042470499392
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",3499,84,1.22 [0.86-1.74],0.2568507194119437
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,4238,160,1.05 [0.78-1.42],0.7360728908075866
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,42368,164,0.92 [0.66-1.27],0.604476244003352
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,42980,1721,0.98 [0.89-1.08],0.6986968391675151
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",42694,1145,1.03 [0.92-1.15],0.6616063686978826
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,41922,373,1.11 [0.92-1.33],0.2852387886826256
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",43183,1204,1.03 [0.93-1.15],0.5417817600347328
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,43305,116,1.02 [0.71-1.46],0.9164975191919272
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,43068,1089,1.06 [0.95-1.19],0.2706240624199644
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",43251,611,1.03 [0.88-1.20],0.7222730446714734
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,43166,304,0.86 [0.67-1.11],0.2566422224013061
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,41651,102,0.89 [0.58-1.37],0.6096547018083834
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,41661,112,0.99 [0.68-1.44],0.959606542659056
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,41644,95,1.20 [0.86-1.68],0.2886935591740643
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,43168,1180,0.93 [0.83-1.06],0.2766331013392805
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,42303,315,0.84 [0.65-1.08],0.1667252627577749
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,42054,75,0.90 [0.55-1.47],0.6730987996160995
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,42804,164,1.04 [0.77-1.39],0.8167615900515641
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,43100,460,1.04 [0.87-1.24],0.6609673983293212
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,42309,330,1.03 [0.84-1.27],0.7556377718728226
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,43045,183,0.82 [0.58-1.15],0.2423360853899909
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,42755,767,0.98 [0.84-1.13],0.7368267012203232
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,42434,230,1.10 [0.87-1.39],0.4104053749575436
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,40674,3641,0.97 [0.91-1.04],0.4083656634630893
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,43042,402,1.03 [0.86-1.25],0.7272065274637101
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,43282,256,0.97 [0.75-1.24],0.7946160464260832
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,42228,679,1.03 [0.89-1.19],0.7126159097419369
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,42752,112,0.86 [0.56-1.31],0.4829316764496186
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,43282,93,0.92 [0.59-1.42],0.6919212425028483
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,41691,142,1.28 [0.99-1.65],0.0630347732025162
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,41801,252,0.96 [0.74-1.24],0.7607948365304747
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,41450,191,0.76 [0.54-1.08],0.1274277189402907
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,42070,91,0.86 [0.54-1.36],0.5164398302721633
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",41363,104,0.57 [0.33-0.96],0.0344386879865563
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,42131,143,0.70 [0.46-1.06],0.0885733022439618
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",42312,324,0.94 [0.75-1.19],0.6105493765091347
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,41748,199,1.17 [0.92-1.49],0.1938476342831843
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,41440,181,1.29 [1.05-1.59],0.0155086897669498
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,41392,133,0.68 [0.44-1.06],0.0871835552345353
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,40005,2972,0.99 [0.92-1.06],0.7163409301179863
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,41672,123,1.12 [0.81-1.54],0.4928561190250278
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,42887,683,0.96 [0.82-1.12],0.6151170234229886
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,42299,95,0.90 [0.58-1.40],0.640364782681625
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),42474,270,0.92 [0.71-1.18],0.5055581969988654
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,42947,149,0.87 [0.60-1.24],0.4278743834418156
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,43243,198,1.04 [0.80-1.36],0.7809020414734943
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,43102,217,0.87 [0.64-1.16],0.3385110510545708
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,42904,106,1.12 [0.80-1.56],0.513009050919087
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,42909,111,0.89 [0.60-1.34],0.5882833429160402
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,43144,1444,0.90 [0.81-1.01],0.0783030517735595
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,42737,1037,0.92 [0.81-1.05],0.2374521665890159
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,41907,207,0.93 [0.69-1.24],0.6130327269113571
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,41838,138,0.91 [0.64-1.31],0.623331842093383
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Acute pharyngitis,42898,121,0.90 [0.61-1.32],0.5904143911691924
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,43137,360,1.05 [0.87-1.28],0.6129670215736055
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,42882,105,0.91 [0.61-1.38],0.6699179655344987
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,All influenza,40036,191,1.07 [0.82-1.40],0.6324024573996789
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),40032,187,1.05 [0.80-1.39],0.7276989877015055
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Allergic asthma (mode),29722,198,1.17 [0.93-1.48],0.1684281571606746
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Allergic rhinitis,43108,470,0.88 [0.72-1.07],0.1891280795293848
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",32071,2989,1.00 [0.93-1.07],0.9949669593254448
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",32471,2947,1.00 [0.93-1.07],0.9018794332705302
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),42645,233,1.11 [0.88-1.41],0.3745779409117014
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",39978,133,1.24 [0.94-1.64],0.1239166319606761
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Bronchiectasis,37509,583,1.05 [0.90-1.23],0.5080766424421544
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",37019,93,0.76 [0.46-1.25],0.2797379369721096
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,41614,4688,1.00 [0.95-1.06],0.9510687397982774
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",41007,124,0.84 [0.56-1.25],0.3970463886181211
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Chronic sinusitis,41137,254,1.09 [0.87-1.36],0.4638338486778379
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",42986,1966,1.00 [0.91-1.09],0.94785791431921
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Deviated nasal septum,41073,190,0.88 [0.64-1.20],0.4110088358750584
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,39831,8736,0.98 [0.94-1.02],0.2976003722312093
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",41509,626,0.93 [0.79-1.10],0.4110978825824788
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Early onset COPD,41557,537,0.89 [0.74-1.08],0.2494339130378324
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Emphysema,37452,526,1.06 [0.90-1.25],0.4714607961957958
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,41089,492,1.16 [1.00-1.36],0.0549947263795891
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Influenza and pneumonia,42939,3094,1.04 [0.97-1.12],0.2426359927951241
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Interstitial lung disease,41143,546,1.17 [1.01-1.35],0.0326234647598648
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Later onset COPD,41613,1429,1.03 [0.93-1.14],0.5946594694129388
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,43297,504,0.92 [0.76-1.11],0.3778313954703087
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Nasal polyp,41069,186,0.90 [0.66-1.23],0.5021973129312645
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,42887,1589,0.93 [0.84-1.03],0.1745088135868316
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other diseases of pleura,42924,3297,1.02 [0.96-1.09],0.5054049033601244
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,42292,1409,0.93 [0.83-1.04],0.1873955187263773
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other pleural conditions,39710,83,0.92 [0.58-1.46],0.7274277962323803
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,43151,680,1.19 [1.05-1.35],0.0070671441100071
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,43138,2159,1.04 [0.96-1.13],0.3830215044994378
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pleural effusion,41244,1617,1.05 [0.95-1.15],0.3531950837940714
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pleural plaque,39890,263,0.90 [0.69-1.18],0.4426503715177987
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",42519,2674,1.04 [0.97-1.12],0.2475321118245751
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,43186,393,0.94 [0.76-1.16],0.5477036772156597
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pneumothorax,39832,205,0.85 [0.63-1.16],0.3177933268244652
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pollen allergy,43279,398,0.87 [0.70-1.08],0.2052010576034139
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pulmonary oedema,42583,112,1.25 [0.93-1.68],0.1410983042170288
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Respiratory insufficiency,29613,89,0.96 [0.62-1.46],0.8364106935247542
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,42853,1555,0.93 [0.84-1.04],0.2073697032702229
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,41354,471,0.87 [0.72-1.06],0.1769361918880675
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Viral pneumonia,40254,409,1.01 [0.83-1.23],0.926318360440483
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",42674,338,1.04 [0.85-1.29],0.6837527676954311
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,20022,179,1.01 [0.75-1.35],0.9564117263806068
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,30688,109,0.94 [0.63-1.40],0.7664589110795546
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute appendicitis,43043,242,0.90 [0.68-1.17],0.4257525373120152
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute gastritis,32670,142,1.18 [0.90-1.56],0.2324296973912073
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute pancreatitis,40237,312,0.91 [0.71-1.15],0.4150784342758169
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute peritonitis,42540,150,1.11 [0.83-1.48],0.4983909004003213
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Alcoholic liver disease,41817,121,0.94 [0.64-1.38],0.7598018291345019
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Barrett oesophagus,33252,724,0.96 [0.82-1.11],0.5666557201032211
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",40095,170,1.06 [0.80-1.41],0.6655821313076344
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",42623,170,1.07 [0.80-1.42],0.6548271460837154
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Cholecystitis,40257,332,0.95 [0.76-1.19],0.6537621437356543
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Cholelithiasis,41609,1684,1.00 [0.91-1.10],0.992083590723102
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Chronic gastritis,33029,501,1.01 [0.85-1.21],0.8764593317819218
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Chronic pancreatitis,40007,82,1.18 [0.82-1.69],0.3758142756339885
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",43081,178,1.07 [0.81-1.41],0.634323994929243
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Coeliac disease,40633,200,1.63 [1.41-1.88],3.4391954838753406e-11
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Collagenous colitis,40499,136,0.73 [0.48-1.11],0.1406487001694226
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,43050,319,0.93 [0.73-1.17],0.5149656487020625
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Constipation,42899,2723,0.95 [0.88-1.03],0.2244378487143153
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Crohn disease,40509,146,0.85 [0.59-1.22],0.3722898960789236
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",42724,105,0.91 [0.60-1.37],0.64776071522439
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Crohn's disease NAS,40501,138,0.87 [0.60-1.26],0.448045023060311
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Dental caries,42077,386,1.03 [0.84-1.24],0.7998771979608161
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,38913,3688,1.06 [1.00-1.13],0.0441306702766845
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of appendix,43107,306,0.94 [0.74-1.18],0.584111529304727
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of liver,43120,1424,1.03 [0.93-1.14],0.5755374338888969
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",39681,7153,1.00 [0.96-1.05],0.9668832412410896
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",42618,927,1.06 [0.94-1.20],0.3182477895617225
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of peritoneum,43175,785,1.13 [1.00-1.28],0.047079765082245
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,41881,190,1.11 [0.86-1.43],0.4270923020815217
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of salivary glands,41642,106,1.33 [1.01-1.74],0.0398584697264297
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of the digestive system,42804,2371,1.14 [1.06-1.22],0.0003489787887999
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of tongue,41658,184,0.94 [0.69-1.27],0.6744005462559142
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",42288,2363,0.99 [0.92-1.08],0.8906024653462878
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,35872,5293,0.98 [0.93-1.04],0.5287119969606109
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Duodenal ulcer,32857,329,0.76 [0.58-0.99],0.0386790660133297
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",43173,261,0.74 [0.55-1.01],0.0544643774805615
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,43173,92,1.15 [0.82-1.61],0.4098938762134093
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,41910,214,1.15 [0.91-1.44],0.2509156235643575
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,30826,247,0.88 [0.67-1.16],0.3792335457910012
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Functional dyspepsia,33448,920,1.01 [0.89-1.15],0.8580514082527911
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastric ulcer,33134,606,1.06 [0.91-1.23],0.4826485808285922
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,36681,4153,0.96 [0.90-1.02],0.1569286479227623
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,33427,899,0.97 [0.85-1.12],0.7050726783385098
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,33551,13827,1.01 [0.98-1.04],0.5307899552511943
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,GI-bleeding,42354,1921,1.05 [0.96-1.14],0.2597994710559022
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,41795,104,1.15 [0.83-1.60],0.3886904369133801
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,32181,2082,0.98 [0.90-1.07],0.7248077900983378
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",41798,102,1.06 [0.73-1.53],0.7702600193104849
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Hernia,40597,5372,1.08 [1.02-1.13],0.0035427412154909
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Impacted teeth,43184,86,1.18 [0.85-1.66],0.3274113821729205
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Impaction of intestines,30671,92,1.17 [0.83-1.64],0.3665521363577482
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Inguinal hernia,36733,1508,1.08 [0.98-1.18],0.1196607986581994
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",35391,166,1.12 [0.86-1.47],0.4035906264260356
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,30741,162,0.89 [0.64-1.25],0.5084207734617199
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Intestinal malabsorption,40671,238,1.55 [1.34-1.79],2.532727467289528e-09
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,31510,931,0.91 [0.80-1.04],0.1800469051599303
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,43272,611,1.03 [0.88-1.20],0.7286841983319727
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,41624,1261,1.06 [0.95-1.17],0.3088363773391686
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,42038,1675,1.01 [0.92-1.11],0.8515686006638998
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oesophageal obstruction,32836,308,0.91 [0.72-1.16],0.4539132208698679
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oesophagitis,33541,1013,1.02 [0.90-1.15],0.7897667709066117
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,43234,229,1.04 [0.81-1.33],0.7689993921048659
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,35338,113,1.06 [0.74-1.51],0.7528752362332465
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,32869,2290,1.04 [0.96-1.12],0.3696367432763876
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,40390,465,1.05 [0.89-1.25],0.5647379488804765
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,40185,260,1.02 [0.81-1.29],0.8819803356438397
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of intestine,33508,2929,1.00 [0.93-1.08],0.9530950654451432
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of intestines,39952,9373,0.99 [0.95-1.03],0.6857982778637124
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,41633,348,1.04 [0.85-1.27],0.6908174746198965
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of liver,42857,1161,1.05 [0.95-1.18],0.3381012873837377
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,33636,1108,1.02 [0.91-1.14],0.7642889565199944
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of pancreas,40171,246,0.87 [0.66-1.15],0.330920841724632
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,43065,675,1.12 [0.98-1.28],0.0938605156969561
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,34118,1590,1.02 [0.93-1.12],0.6673208995442659
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,42379,1946,1.05 [0.96-1.14],0.2626313265770452
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,41986,295,1.19 [0.98-1.44],0.0723654695643375
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,33381,2802,0.96 [0.89-1.04],0.3215733497995932
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),35852,3324,1.05 [0.98-1.12],0.1792190836682525
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,41863,167,1.18 [0.91-1.52],0.2058423159922038
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,41837,1474,1.02 [0.93-1.13],0.646141719638101
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",31147,568,0.97 [0.82-1.14],0.7043092167659264
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,43156,109,1.11 [0.81-1.54],0.5070953542476625
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,31394,815,1.04 [0.91-1.18],0.599946072508315
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",40695,262,1.26 [1.04-1.52],0.0180455556324123
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Recurring oral aphthae,43298,98,1.11 [0.78-1.57],0.5758158932172626
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,41699,200,1.03 [0.79-1.34],0.8280369944616615
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Toxic colitis,40453,90,0.98 [0.64-1.49],0.9134368149534676
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,32986,458,0.98 [0.82-1.19],0.8676509130244275
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ulcerative colitis,40626,263,1.00 [0.79-1.27],0.9973643738453892
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",40581,218,1.02 [0.79-1.32],0.8867146440923723
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Umbilical hernia,35666,441,0.90 [0.73-1.11],0.3169220934057478
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,30873,294,0.82 [0.63-1.06],0.1313900459111791
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ventral hernia,35650,425,1.17 [1.00-1.38],0.0569976799340492
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Volvulus,30712,133,1.39 [1.10-1.74],0.0049251786541322
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,43192,476,1.15 [0.99-1.35],0.0717903597828117
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,42785,133,0.89 [0.61-1.28],0.518932154743086
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,39948,273,1.00 [0.79-1.26],0.996404868442626
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,42241,1165,1.03 [0.92-1.15],0.6307346919578094
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",41372,296,1.21 [1.01-1.46],0.0371069283786903
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,40304,629,1.18 [1.03-1.35],0.0147704007895639
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,42804,461,1.04 [0.87-1.24],0.6891454042870346
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,43142,799,1.08 [0.95-1.23],0.217372069708911
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,42422,79,0.95 [0.60-1.50],0.833075907320998
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,40691,5298,1.02 [0.97-1.07],0.4688345116896886
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,42549,738,1.02 [0.89-1.17],0.7783456347714519
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,42325,514,0.97 [0.81-1.16],0.7244908464863026
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,42648,1572,1.07 [0.97-1.17],0.1722835618619797
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",43290,91,1.08 [0.74-1.57],0.6874458808813791
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,39784,109,1.17 [0.85-1.61],0.3255476639446145
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,41901,90,1.21 [0.87-1.70],0.2594598073285342
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,42786,443,0.99 [0.82-1.19],0.9213286631990418
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,40431,756,0.96 [0.83-1.11],0.5671116841105855
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,39788,113,0.84 [0.55-1.28],0.4129252988587826
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,43180,134,1.22 [0.93-1.60],0.1491095072339262
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,41367,291,0.99 [0.78-1.25],0.942527047985551
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,42973,321,0.95 [0.75-1.19],0.635767087835702
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,42439,96,1.29 [0.95-1.74],0.0998340280978429
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,39781,106,0.65 [0.40-1.08],0.0945348156543948
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,42351,2676,1.04 [0.97-1.12],0.2621955847541195
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",40499,824,0.94 [0.81-1.08],0.3853152884083961
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,39793,118,0.90 [0.61-1.34],0.610470626631142
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,43170,518,1.00 [0.84-1.18],0.958572117081498
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,42463,120,1.26 [0.95-1.66],0.1136246284504554
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,43076,424,0.99 [0.82-1.20],0.9230918224300342
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,43233,517,1.12 [0.96-1.31],0.1375133739749211
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,39892,217,0.95 [0.72-1.24],0.6872865768371466
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,40117,442,1.01 [0.84-1.21],0.9025384347738136
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,43217,501,1.13 [0.97-1.32],0.1299904031301798
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",40047,372,1.24 [1.05-1.45],0.0093256864884706
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,43269,223,1.08 [0.85-1.38],0.5335858594942455
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,37135,183,0.94 [0.69-1.26],0.6645087294179188
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,39418,9402,0.96 [0.92-1.00],0.0489034017333679
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,37079,7063,0.94 [0.89-0.98],0.007562998474513
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,37082,130,1.00 [0.71-1.40],0.9808889640923164
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,37592,253,0.71 [0.52-0.97],0.0302129844875205
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,37638,299,1.05 [0.85-1.30],0.6620417304696877
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,42900,151,0.77 [0.52-1.13],0.1832745396706452
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",37506,167,0.93 [0.67-1.29],0.6701760526921107
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,31930,1914,0.89 [0.81-0.98],0.0216262777741937
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",43079,323,0.83 [0.65-1.07],0.1537013841582175
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,38054,715,1.01 [0.88-1.17],0.873257397042829
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,36605,12117,0.98 [0.95-1.02],0.259920653600775
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,40033,194,1.01 [0.77-1.34],0.9237701442321108
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,37201,249,1.04 [0.82-1.33],0.7326656369150484
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,37920,968,0.82 [0.71-0.95],0.0075080503086662
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,41747,4408,0.99 [0.93-1.05],0.7315395228085015
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,37420,468,1.02 [0.86-1.22],0.8216721790034308
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,37333,381,1.02 [0.85-1.24],0.803456516648715
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,37186,234,0.73 [0.53-0.99],0.0460838427890563
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,42201,121,1.14 [0.84-1.56],0.3952750761863233
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,32826,2810,0.95 [0.88-1.03],0.1926307574105238
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,30988,972,1.06 [0.94-1.19],0.3354702060532077
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",43193,956,1.06 [0.94-1.19],0.3697944382850707
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,30142,126,1.04 [0.75-1.44],0.8149308650757139
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),30579,563,0.79 [0.65-0.96],0.0175248036468475
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,37464,512,0.93 [0.78-1.12],0.4398923620720736
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,31085,1069,0.94 [0.83-1.06],0.3299699779684273
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,37427,88,1.06 [0.71-1.58],0.7911442236160008
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,38386,1047,0.96 [0.85-1.09],0.5105809122308341
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,37841,502,0.83 [0.68-1.01],0.0688115170285101
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,31012,996,0.93 [0.82-1.06],0.2925092454479222
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,37080,128,0.93 [0.64-1.34],0.6937461708523891
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",37053,101,0.89 [0.58-1.36],0.5767619588116667
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,39954,115,0.80 [0.52-1.24],0.3211272833791572
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,42673,2834,1.04 [0.97-1.11],0.321556889361687
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,41701,1862,1.08 [1.00-1.18],0.0609558590137449
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",43072,753,1.03 [0.90-1.19],0.6272253486519861
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,34170,4154,0.95 [0.89-1.01],0.130043076180075
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,30118,102,0.82 [0.53-1.28],0.3894390403437544
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,37104,152,0.80 [0.55-1.16],0.2453757480532571
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,30107,91,0.99 [0.66-1.49],0.9685077302543876
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),30226,210,1.15 [0.92-1.44],0.2295566115511049
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,40246,407,0.92 [0.75-1.13],0.4328601639804518
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,40451,612,1.07 [0.92-1.24],0.3931985570932873
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,43266,162,0.95 [0.69-1.31],0.7580316180289921
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",40332,2993,0.98 [0.91-1.05],0.5530577858001262
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,37118,166,0.95 [0.69-1.29],0.7245247330496636
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),30250,234,0.83 [0.62-1.11],0.2158365116598961
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,38549,1210,0.94 [0.83-1.06],0.2927944680494441
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,33608,3592,0.92 [0.86-0.98],0.0166141828411265
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,42237,157,1.26 [0.99-1.61],0.0627999806437737
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,43288,127,0.90 [0.62-1.31],0.5858173274061363
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,37088,136,1.00 [0.71-1.40],0.9913331308290778
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",39028,2076,1.04 [0.96-1.13],0.293887372542442
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,37096,144,1.07 [0.79-1.46],0.665910377314056
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,32719,2703,0.95 [0.87-1.02],0.1612384868144164
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,40034,195,0.86 [0.63-1.18],0.3542789418091659
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,37038,86,0.69 [0.41-1.18],0.1763850637355745
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,37604,265,1.14 [0.92-1.41],0.2236847311545585
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,37852,900,1.11 [0.98-1.25],0.0924208997533942
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,42688,608,1.07 [0.93-1.25],0.339095692278053
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,38294,955,0.98 [0.86-1.12],0.7946105526374043
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,43092,733,1.03 [0.89-1.18],0.7034952893496416
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,43284,90,0.87 [0.55-1.38],0.5681546748230588
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,37272,320,0.86 [0.68-1.10],0.2379826118205684
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,34267,1250,0.90 [0.80-1.02],0.0914922384841701
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,37917,965,1.03 [0.91-1.16],0.6296690144166993
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],37342,390,0.98 [0.80-1.20],0.8314520032956462
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",30112,96,1.07 [0.74-1.55],0.7003471239160388
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,34151,4135,0.98 [0.93-1.05],0.62625922362919
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,31105,1089,0.82 [0.72-0.94],0.0048792258556234
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,42469,389,1.00 [0.82-1.22],0.9695601158894036
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",43206,102,1.05 [0.73-1.51],0.8014962861332661
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",39710,82,0.69 [0.39-1.21],0.1933267942607751
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,30146,130,0.88 [0.61-1.28],0.510349932622058
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,37506,167,0.95 [0.69-1.30],0.7461461250726777
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,30779,763,1.04 [0.90-1.19],0.6071706495285861
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,37470,518,0.88 [0.72-1.06],0.1735848694497065
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,37762,423,0.97 [0.80-1.18],0.742060176166895
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,37643,304,0.94 [0.74-1.19],0.6058208740587432
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,33881,101,0.93 [0.62-1.40],0.7314208838889213
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",43290,96,0.94 [0.62-1.43],0.7679485243916517
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,37942,990,0.96 [0.84-1.09],0.5078404620937311
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],42242,162,1.24 [0.97-1.58],0.0832533526032503
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,41278,4326,0.99 [0.93-1.05],0.6886773858270825
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",37174,222,1.18 [0.94-1.47],0.1502285264525421
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,38226,887,1.02 [0.90-1.16],0.7353978645758804
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,40926,388,1.06 [0.87-1.28],0.5700977148926942
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,37667,328,1.07 [0.87-1.31],0.5085255801917603
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,39901,2562,0.98 [0.90-1.06],0.5478234762298955
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,39011,1672,0.97 [0.88-1.07],0.5729244355686383
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],37039,87,0.83 [0.51-1.35],0.4529928508745801
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,42321,241,1.20 [0.97-1.47],0.0922183388977455
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,37231,279,0.84 [0.64-1.10],0.1971110677120479
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,37082,130,1.26 [0.96-1.65],0.092896189947884
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),30108,92,1.27 [0.94-1.74],0.1247776739832976
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Acute renal failure,41760,2508,1.03 [0.96-1.11],0.4288616193615276
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17527,85,0.99 [0.66-1.48],0.9596220986264398
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,22857,97,1.16 [0.83-1.61],0.3910414771483294
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,42786,528,1.02 [0.87-1.21],0.795624837997644
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,42404,146,0.96 [0.69-1.34],0.8055899132052529
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,41510,2258,1.13 [1.05-1.22],0.0015596333396679
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,42986,103,1.12 [0.79-1.59],0.5185112167725072
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,42956,482,1.12 [0.95-1.31],0.1643568839434154
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Cystitis,38237,380,1.05 [0.87-1.27],0.6058827906498712
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Dialysis,39360,108,1.28 [0.94-1.72],0.111723649802076
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,18818,2749,0.94 [0.87-1.02],0.1367408673692292
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23040,280,1.14 [0.93-1.39],0.2017050067739423
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Endometriosis,17590,148,1.01 [0.75-1.36],0.9249054347098102
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",17776,334,0.92 [0.75-1.14],0.4407752798355058
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18302,860,0.98 [0.86-1.12],0.7638617413537759
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,36152,8835,1.02 [0.98-1.07],0.2514961469981557
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,43004,121,1.25 [0.95-1.65],0.1070023635814837
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Hydrocele,16244,175,0.66 [0.45-0.97],0.0331903034734613
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,39210,464,0.88 [0.72-1.08],0.2347170259749061
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18218,2149,0.95 [0.87-1.04],0.2746965060199738
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,22978,339,0.98 [0.79-1.21],0.825873948040286
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16266,197,0.73 [0.52-1.04],0.0792648421986887
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Irregular menses,23056,107,0.82 [0.54-1.24],0.3500827274397852
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Menorrhagia,17705,263,0.96 [0.76-1.20],0.6913779664797626
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,37984,127,0.78 [0.51-1.18],0.2432623384713509
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19514,2072,1.01 [0.93-1.10],0.747113085300492
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16168,99,0.89 [0.57-1.38],0.5962716137298687
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17557,115,1.08 [0.79-1.48],0.625569387009322
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",43304,108,0.96 [0.65-1.42],0.8470119655874884
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",43304,106,1.37 [1.06-1.79],0.0179815974247107
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,41559,3702,0.99 [0.93-1.06],0.8082824731243875
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,39062,1205,1.00 [0.90-1.12],0.9427370564154448
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,22858,98,1.15 [0.82-1.60],0.4262923659014772
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,43218,744,1.16 [1.02-1.31],0.0227421878575419
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16327,258,0.89 [0.68-1.16],0.3899061323552736
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16306,237,0.88 [0.66-1.17],0.3822845101517523
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16257,188,0.88 [0.64-1.22],0.4451570769327496
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,43259,117,0.99 [0.69-1.42],0.9694415258890056
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,40677,2820,1.01 [0.94-1.08],0.8509362674730875
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,22814,175,1.01 [0.76-1.34],0.9659417216534808
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17577,135,0.82 [0.56-1.20],0.3034363663453474
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17773,331,0.84 [0.66-1.07],0.1563902165756968
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17539,97,1.24 [0.92-1.68],0.1589587496080449
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17616,174,0.78 [0.55-1.11],0.1718342924827839
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,39287,541,0.91 [0.76-1.10],0.3285427065237087
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,42720,246,1.11 [0.88-1.39],0.3722573638147299
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17702,260,1.18 [0.97-1.43],0.093890519520028
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17532,90,0.97 [0.66-1.44],0.896234550960342
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,17979,537,1.08 [0.94-1.26],0.2831920980307754
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17579,137,0.94 [0.67-1.33],0.7254834984214107
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,17937,495,1.09 [0.94-1.27],0.259075863511682
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,42970,87,0.99 [0.65-1.51],0.9716481212480986
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16289,220,1.17 [0.93-1.46],0.1761353830527197
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,42966,4220,1.06 [1.00-1.12],0.0594574004331385
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",38941,195,1.08 [0.83-1.40],0.5682689347325374
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,39439,187,0.97 [0.72-1.31],0.8309780709617651
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,42352,94,0.94 [0.61-1.43],0.7606675958558533
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Urethral stricture,38231,374,1.00 [0.82-1.23],0.9618680052911294
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Urolithiasis,42921,663,1.00 [0.86-1.17],0.958070381201392
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17560,118,1.03 [0.74-1.43],0.8826073254962623
